biomedicina slovenica


"ALENDRONATE" : 38

  1. Čokolič Miro
    Male patients with idiopathic osteoporosis and long term alendronate care
    2009
  2. Čokolič Miro; Hren Rok
    Alendronate is safe and effective during long-term therapy in patients with osteoporosis and impaired fasting glucose
    2004
  3. Marc Janja; Ostanek Barbara; Preželj Janez; Kocijančič Andreja
    RSAI polimorphism of Er-beta gene and alendronate treatment of osteoporosis
    2001
  4. Čokolič Miro; Hren Rok
    A five-year alendronate treatment of postmenopausal osteoporosis in patients with impaired fasting glucose
    2004
  5. Kocjan Tomaž; Jensterle Sever Mojca; Pfeifer Marija; Sabati Rajić Antonela; Bajuk-Studen Katica; Preželj Janez
    Evaluation of three regimens of cholecalciferol dosing in osteoporotic postmenopausal women treated with alendronate
    2013
  6. Kocjan Tomaž; Jensterle Sever Mojca; Pfeifer Marija; Sabati Rajić Antonela; Bajuk-Studen Katica; Preželj Janez
    Suppression of undercarboxylated osteocalcin by alendronate is associated with atransient decrease of insulin sensitivity and adiponectin in women with osteoporosis
    2014
  7. Čokolič Miro; Rakuša Matej
    Effect of two-year alendronate withdrawal after five years of treatment and retreatment benefits of bisphosphonates in patients with postmenopausal osteoporosis
    2010
  8. Čokolič Miro
    Male patients with idiopathic osteoporosis and long term alendronate care
    2008
  9. Čokolič Miro
    Alendronate long-term treatment of idiopathic osteoporosis in men
    2008
  10. Jurković Mlakar Simona; Preželj Janez; Marc Janja
    Polyalanine repeats gene polymorphism of GPX1 antioxidant enzyme in postmenopausal osteoporotic women predict alendronate therapy outcome
    2011
  11. Kovač Damjan; Kandus Aljoša; Benedik Miha; Lindič Jelka; Coer Andrej; Legan Mateja; Stopar-Gmeiner Tanja
    Alendronate treatment in kidney transplantant recipients
    2008
  12. Čokolič Miro; Hren Rok
    Remaining effects of a five-year alendronate treatment in patients with post-menopausal osteoporosis and impaired fasting glucose
    2006
  13. Čokolič Miro; Hren Rok
    Treatment of postmenopausal osteoporosis with alendronate and calcium in patients with impaired fasting glucose
    2000
  14. Cokolič M; Hren R
    Effect of two-year discontinuation after five years of alendronate treatment in patients with postmenopausal osteoporosis and impaired fasting glucose
    2006
  15. Cokolič Miro; Hren Rok
    Effect of two-year discontinuation after five years alendronate treatment in patients with postmenopausal osteoporosis and impaired fasting glucose
    2006
  16. Cokolič Miro; Hren Rok
    Effect of two-year discontinuation after five years of alendronate treatment in patients with postmenopausal osteoporosis
    2006
  17. Plešivčnik-Novljan Martina; Ambrožič Aleš; Tomšič Matija
    The role of calcium, vitamin D and alendronate in prevention of steroid induced osteoporosis
    2006
  18. Kovač Damjan; Kandus Aljoša; Benedik Miha; Lindič Jelka; Coer Andrej; Legan Mateja; Bren Andrej
    Bone histopathology and mineral density in kidney transplant recipients after one year of alendronate treatment
    2005
  19. Kocjan Tomaž
    Dolgotrajno zdravljenje osteoporoze z alendronatom
    [Treatment of osteoporosis with alendronat]
    2005
  20. Čokolič M; Hren R
    A five-year alendronate treatment of postmenopausal osteoporosis in patients with impaired fasting glucose
    2004
  21. Kocijančič Andreja
    Smernice za odkrivanje in zdravljenje osteoporoze po zlomu pri starostniku
    2003
  22. Džajkovska Biljana
    Pharmacoeconomic analysis of different drug treatments for osteoporosis
    [Farmakoekonomska analiza različnih zdravljenj osteoporoze]
    2003
  23. Cokolič M; Hren R
    Impaired fasting glucose and treatment of postmenopausal osteoporosis with alendronate
    2003
  24. Čokolič M; Hren R
    Idiopathic osteoporosis in male patients: assessment and treatment
    2003
  25. Kovač Damjan; Lindič Jelka; Kandus Aljoša; Bren Andrej F
    Prevention of bone loss with alendronate in kidney transplant recipients
    2000
  26. Čokolič M
    Treatment of idiopathic male osteoporosis with alendronate
    2003
  27. Arko Barbara; Preželj Janez; Komel Radovan; Kocijančič Andreja; Marc Janja
    No major effect of estrogen receptor beta gene RsaI polymorphism on bone mineral density and response to alendronate therapy in postmenopausal osteoporosis
    2002
  28. Hren R; Čokolič M
    Alendronate is a first-line therapy of postmenopausal women with osteoporosis in Slovenia
    2002
  29. Čokolič M; Hren R
    Alendronate appears effective in treating idiopathic osteoporosis in men
    2002
  30. Čokolič M; Hren R
    Treatment of idiopathic osteoporosis in male patients using alendronate
    2002
  31. Čokolič M; Hren R
    Alendronate treatment of male patients with idiopathic osteoporosis
    2002
  32. Čokolič Miro; Hren R
    Alendronate treatment of patients with postmenopausal osteoporosis and impaired fasting glucose
    2001
  33. Kovač Damjan; Lindič Jelka; Kandus Aljoša; Bren Andrej F
    Prevention of bone loss with alendronate in kidney transplant recipients
    2000
  34. Kovač Damjan; Lindič Jelka; Kandus Aljoša; Bren Andrej F
    Alendronate prevents bone loss in kidney graft recipients
    2000
  35. Salobir Boštjan
    Zdravljenje osteoporoze
    2000
  36. Bauer Douglas C; Black Dennis; Ensrud Kristine; Thompson Dasmond; Hochberg Mare; Nevitt Michael; Musliner Thomas; Freeholm Debra
    Profil varnosti zgornjega gastrointestinalnega trakta pri zdravljenju a alendronatom: študija: "The fracture intervention trial"
    [(Upper gastrointestinal tract safety profile of alendronate. The fracture intervention trial)]
    2000
  37. Pols HAP; Felsenberg D; Hanley DA; Štepan J; Munoz-Torres M; Wilkin TJ; Qin-Sheng G; Galich AM; Vandormael K; Kocijančič A; et al ;
    Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass: results of the FOSIT study
    1999
  38. Salobir Boštjan
    Zdravljenje osteoporoze po zlomu
    1999



New search      Comments      Top of page Institute for Biostatistics and Medical Informatics